CN105189729B - 用于组织处理以及由其制备细胞悬液的系统和方法 - Google Patents
用于组织处理以及由其制备细胞悬液的系统和方法 Download PDFInfo
- Publication number
- CN105189729B CN105189729B CN201480025699.5A CN201480025699A CN105189729B CN 105189729 B CN105189729 B CN 105189729B CN 201480025699 A CN201480025699 A CN 201480025699A CN 105189729 B CN105189729 B CN 105189729B
- Authority
- CN
- China
- Prior art keywords
- tissue
- applicator
- cartridge
- cell
- chamber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000006285 cell suspension Substances 0.000 title claims abstract description 97
- 238000012545 processing Methods 0.000 title claims description 96
- 238000000034 method Methods 0.000 title abstract description 58
- 238000002360 preparation method Methods 0.000 title description 2
- 210000001519 tissue Anatomy 0.000 claims abstract description 213
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 109
- 108090000790 Enzymes Proteins 0.000 claims description 74
- 102000004190 Enzymes Human genes 0.000 claims description 74
- 238000011282 treatment Methods 0.000 claims description 65
- 239000012530 fluid Substances 0.000 claims description 59
- 239000000243 solution Substances 0.000 claims description 50
- 230000007246 mechanism Effects 0.000 claims description 46
- 239000007853 buffer solution Substances 0.000 claims description 32
- 238000002054 transplantation Methods 0.000 claims description 19
- 238000004891 communication Methods 0.000 claims description 18
- 230000033001 locomotion Effects 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000013043 chemical agent Substances 0.000 claims description 16
- 239000008223 sterile water Substances 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 13
- 238000003306 harvesting Methods 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 11
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims description 8
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims description 8
- 210000002744 extracellular matrix Anatomy 0.000 claims description 8
- 238000005507 spraying Methods 0.000 claims description 8
- 239000000758 substrate Substances 0.000 claims description 8
- 238000007789 sealing Methods 0.000 claims description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 5
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 5
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 5
- 239000012620 biological material Substances 0.000 claims description 5
- 239000003102 growth factor Substances 0.000 claims description 5
- 229920002674 hyaluronan Polymers 0.000 claims description 5
- 229960003160 hyaluronic acid Drugs 0.000 claims description 5
- 210000004623 platelet-rich plasma Anatomy 0.000 claims description 5
- 210000000130 stem cell Anatomy 0.000 claims description 5
- 230000000845 anti-microbial effect Effects 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 2
- 208000027418 Wounds and injury Diseases 0.000 abstract description 25
- 206010052428 Wound Diseases 0.000 abstract description 24
- 210000000981 epithelium Anatomy 0.000 abstract description 13
- 230000017423 tissue regeneration Effects 0.000 abstract description 10
- 208000014674 injury Diseases 0.000 abstract description 7
- 210000000056 organ Anatomy 0.000 abstract description 6
- 230000006378 damage Effects 0.000 abstract description 5
- 230000008733 trauma Effects 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 abstract description 4
- 230000008439 repair process Effects 0.000 abstract description 3
- 230000015271 coagulation Effects 0.000 abstract description 2
- 238000005345 coagulation Methods 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 70
- 239000000872 buffer Substances 0.000 description 34
- 210000003491 skin Anatomy 0.000 description 33
- 230000008569 process Effects 0.000 description 32
- 239000000725 suspension Substances 0.000 description 26
- 239000002699 waste material Substances 0.000 description 18
- 238000013461 design Methods 0.000 description 11
- 230000002572 peristaltic effect Effects 0.000 description 11
- 238000005086 pumping Methods 0.000 description 11
- 230000006870 function Effects 0.000 description 8
- 210000002950 fibroblast Anatomy 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 239000007921 spray Substances 0.000 description 7
- 230000009471 action Effects 0.000 description 6
- 238000011049 filling Methods 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000029663 wound healing Effects 0.000 description 6
- 210000002615 epidermis Anatomy 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 230000033115 angiogenesis Effects 0.000 description 4
- 238000001574 biopsy Methods 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 210000004927 skin cell Anatomy 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 230000002792 vascular Effects 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 3
- 206010072170 Skin wound Diseases 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 238000003754 machining Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 229940005581 sodium lactate Drugs 0.000 description 3
- 235000011088 sodium lactate Nutrition 0.000 description 3
- 239000001540 sodium lactate Substances 0.000 description 3
- 238000012384 transportation and delivery Methods 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 206010056340 Diabetic ulcer Diseases 0.000 description 2
- 206010029113 Neovascularisation Diseases 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047642 Vitiligo Diseases 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000002316 cosmetic surgery Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 210000003560 epithelium corneal Anatomy 0.000 description 2
- 230000000762 glandular Effects 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 239000002831 pharmacologic agent Substances 0.000 description 2
- 238000007790 scraping Methods 0.000 description 2
- 238000011272 standard treatment Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 208000005230 Leg Ulcer Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010027145 Melanocytic naevus Diseases 0.000 description 1
- 206010050502 Neuropathic ulcer Diseases 0.000 description 1
- 208000007256 Nevus Diseases 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 108090001109 Thermolysin Proteins 0.000 description 1
- 208000020312 Thickened skin Diseases 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- 230000000758 acidotic effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002491 angiogenic effect Effects 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 108010007093 dispase Proteins 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 210000001821 langerhans cell Anatomy 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000008263 repair mechanism Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 238000012954 risk control Methods 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000007655 standard test method Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008364 tissue synthesis Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 238000013024 troubleshooting Methods 0.000 description 1
- -1 trypsin-EDTA Proteins 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000010388 wound contraction Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M21/00—Bioreactors or fermenters specially adapted for specific uses
- C12M21/08—Bioreactors or fermenters specially adapted for specific uses for producing artificial tissue or for ex-vivo cultivation of tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M45/00—Means for pre-treatment of biological substances
- C12M45/02—Means for pre-treatment of biological substances by mechanical forces; Stirring; Trituration; Comminuting
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M45/00—Means for pre-treatment of biological substances
- C12M45/06—Means for pre-treatment of biological substances by chemical means or hydrolysis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Sustainable Development (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Mechanical Engineering (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
所需细胞悬液体积(CSV) | 活检面积[BA](cm<sup>2</sup>) | 用于制备悬液的缓冲液 |
1.0 | 1 | 1.5 |
1.5 | 2 | 2.0 |
2.0 | 4 | 2.5 |
2.5 | 4 | 3.0 |
3.0 | 4 | 3.5 |
3.5 | 4 | 4.0 |
4.0 | 4 | 4.5 |
5.0 | 9 | 5.5 |
6.0 | 9 | 6.5 |
7.0 | 9 | 7.5 |
8.0 | 9 | 8.5 |
9.0 | 16 | 9.5 |
10.0 | 16 | 10.5 |
11.0 | 16 | 11.5 |
12.0 | 16 | 12.5 |
13.0 | 16 | 13.5 |
14.0 | 16 | 14.5 |
15.0 | 16 | 15.5 |
16.0 | 16 | 16.5 |
Claims (32)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911343417.7A CN111304081A (zh) | 2013-03-14 | 2014-03-14 | 用于组织处理以及由其制备细胞悬液的系统和方法 |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361783422P | 2013-03-14 | 2013-03-14 | |
US61/783,422 | 2013-03-14 | ||
AU2013205148A AU2013205148B2 (en) | 2013-03-14 | 2013-04-13 | Systems and methods for tissue processing and preparation of cell suspension therefrom |
AU2013205148 | 2013-04-13 | ||
PCT/US2014/028944 WO2014153072A1 (en) | 2013-03-14 | 2014-03-14 | Systems and methods for tissue processing and preparation of cell suspension therefrom |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911343417.7A Division CN111304081A (zh) | 2013-03-14 | 2014-03-14 | 用于组织处理以及由其制备细胞悬液的系统和方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105189729A CN105189729A (zh) | 2015-12-23 |
CN105189729B true CN105189729B (zh) | 2020-01-10 |
Family
ID=51628587
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201480025699.5A Active CN105189729B (zh) | 2013-03-14 | 2014-03-14 | 用于组织处理以及由其制备细胞悬液的系统和方法 |
CN201911343417.7A Pending CN111304081A (zh) | 2013-03-14 | 2014-03-14 | 用于组织处理以及由其制备细胞悬液的系统和方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911343417.7A Pending CN111304081A (zh) | 2013-03-14 | 2014-03-14 | 用于组织处理以及由其制备细胞悬液的系统和方法 |
Country Status (9)
Country | Link |
---|---|
US (2) | US10626358B2 (zh) |
EP (2) | EP3674396A1 (zh) |
JP (1) | JP6479757B2 (zh) |
CN (2) | CN105189729B (zh) |
AU (1) | AU2013205148B2 (zh) |
CA (1) | CA2906088A1 (zh) |
ES (1) | ES2759063T3 (zh) |
HK (1) | HK1219291A1 (zh) |
WO (1) | WO2014153072A1 (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPR298901A0 (en) | 2001-02-07 | 2001-03-08 | McComb Foundation, Inc., The | Cell suspension preparation technique and device |
AU2013205148B2 (en) | 2013-03-14 | 2014-10-30 | AVITA Medical Americas, LLC | Systems and methods for tissue processing and preparation of cell suspension therefrom |
PL3233289T3 (pl) | 2014-12-15 | 2020-09-07 | Human Brain Wave S.R.L. | Urządzenie do dezagregacji materiału biologicznego i odpowiadający sposób wytwarzania, i sposób przygotowywania zawiesin komórkowych i mikroprzeszczepów tkankowych |
GB201522097D0 (en) | 2015-12-15 | 2016-01-27 | Cellular Therapeutics Ltd | Cells |
DK3430122T3 (da) * | 2016-03-17 | 2021-08-23 | Synova Life Sciences Inc | Separering, adskillelse og/eller opdeling af celler ved hjælp af mekaniske stød |
WO2018102471A1 (en) | 2016-11-29 | 2018-06-07 | S2 Genomics, Inc. | Method and apparatus for processing tissue samples |
GB201700621D0 (en) | 2017-01-13 | 2017-03-01 | Guest Ryan Dominic | Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue |
US10996146B2 (en) | 2017-06-01 | 2021-05-04 | Becton, Dickinson And Company | Devices for dissociating a biological tissue sample and methods of use thereof |
EP3803324A4 (en) | 2018-06-01 | 2023-02-22 | S2 Genomics, Inc. | METHOD AND DEVICE FOR PROCESSING TISSUE SAMPLES |
US11033295B2 (en) * | 2019-05-06 | 2021-06-15 | Tissuemill Technologies Llc | Atraumatically formed tissue composition, devices and methods of preparation and treatment |
BR112022002161A2 (pt) * | 2019-08-06 | 2022-06-07 | Bd Kiestra Bv | Dispositivo descartável para ventilação de um recipiente vedado e aliquação do mesmo |
CN110639099B (zh) * | 2019-09-29 | 2024-05-17 | 中国科学院苏州生物医学工程技术研究所 | 细胞悬液雾化装置 |
CN110643495A (zh) * | 2019-10-31 | 2020-01-03 | 北京伟力新世纪科技发展股份有限公司 | 一种细胞悬浮液制备装置 |
IL294098A (en) | 2019-12-20 | 2022-08-01 | Instil Bio Uk Ltd | Devices and methods for isolating lymphocytes infiltrating tumors and their use |
US11987787B2 (en) | 2020-07-22 | 2024-05-21 | AVITA Medical Americas, LLC | Devices, methods, and kits for preparing a cell suspension |
CA3200237A1 (en) | 2020-12-01 | 2022-06-09 | Cutiss Ag | Device and method for preparing a cell suspension |
US11879121B2 (en) | 2021-04-20 | 2024-01-23 | CisNovo | Tissue disaggregation system and methods |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1625398A (zh) * | 2002-02-01 | 2005-06-08 | 欧里恩公司 | 一种联合治疗急性心肌梗死的方法 |
CN1878470A (zh) * | 2003-09-17 | 2006-12-13 | 马克罗珀尔生物外科公司 | 在周围血管疾病和相关病症的治疗中使用再生细胞的方法 |
WO2013019154A1 (en) * | 2011-07-29 | 2013-02-07 | General Electric Company | Systems, methods and control laws for cell harvesting |
Family Cites Families (97)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1356794A (en) | 1919-12-27 | 1920-10-26 | Smith John Thomas | Skid-oiler |
US3647632A (en) | 1968-04-11 | 1972-03-07 | Little Inc A | Apparatus for cell culture |
US3608553A (en) | 1969-09-04 | 1971-09-28 | Ultrasonic Systems | Ultrasonic method and apparatus for tissue grafting |
JPS497414A (zh) | 1972-05-24 | 1974-01-23 | ||
US4059486A (en) | 1976-11-03 | 1977-11-22 | Monsanto Company | Cell culture process |
US4377010A (en) | 1978-11-08 | 1983-03-22 | The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland | Biocompatible material comprising a base polymer bulk graft polymerized with an ethylenically unsaturated carboxylic acid |
FR2461002A1 (fr) | 1979-07-13 | 1981-01-30 | Inst Nat Sante Rech Med | Procede pour stimuler la croissance des cellules d'epiderme humain et produits faisant application dudit procede |
US4254226A (en) | 1979-09-13 | 1981-03-03 | Sloan Kettering Institute For Cancer Research | Process for growing human epidermal cells in tissue culture |
US4304866A (en) | 1979-11-14 | 1981-12-08 | Massachusetts Institute Of Technology | Transplantable sheets of living keratinous tissue |
US4350768A (en) | 1980-09-19 | 1982-09-21 | Bristol Myers Company | Method for preparing single cell suspension |
US4510144A (en) | 1981-08-26 | 1985-04-09 | Newport Pharmaceuticals International | Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives |
US4458678A (en) | 1981-10-26 | 1984-07-10 | Massachusetts Institute Of Technology | Cell-seeding procedures involving fibrous lattices |
US4418691A (en) | 1981-10-26 | 1983-12-06 | Massachusetts Institute Of Technology | Method of promoting the regeneration of tissue at a wound |
US5328695A (en) | 1983-03-22 | 1994-07-12 | Massachusetts Institute Of Technology | Muscle morphogenic protein and use thereof |
US4649115A (en) | 1983-03-31 | 1987-03-10 | Sloan-Kettering Institute | Monoclonal antibodies to skin cells |
US4769317A (en) | 1983-06-14 | 1988-09-06 | Hefton John M | Process for growing human epidermis, product thereof |
US5000963A (en) | 1983-06-14 | 1991-03-19 | Hefton John M | Method of treating the skin using human epidermal sheets |
US5441539A (en) | 1985-06-06 | 1995-08-15 | Thomas Jefferson University | Endothelial cell deposition device |
US5035708A (en) | 1985-06-06 | 1991-07-30 | Thomas Jefferson University | Endothelial cell procurement and deposition kit |
US5460939A (en) | 1986-04-18 | 1995-10-24 | Advanced Tissue Sciences, Inc. | Temporary living skin replacement |
US5079160A (en) | 1987-06-08 | 1992-01-07 | Lacy Paul E | Method to isolate clusters of cell subtypes from organs |
US5015584A (en) | 1987-10-14 | 1991-05-14 | Board Of Regents, The University Of Texas System | Epidermal graft system |
GB8816516D0 (en) | 1988-07-12 | 1988-08-17 | Welsh Water Authority | Portable incubator and incubating kit |
JPH0372872A (ja) | 1988-07-12 | 1991-03-28 | Bio Kagaku Kenkyusho:Kk | 無血清培地及びそれを用いた哺乳類細胞の培養法 |
US5292655A (en) | 1990-01-29 | 1994-03-08 | Wille Jr John J | Method for the formation of a histologically-complete skin substitute |
EP0444270A1 (en) | 1990-02-26 | 1991-09-04 | Thomas Jefferson University | Endothelial cell deposition device |
US5145770A (en) | 1990-06-04 | 1992-09-08 | Biosurface Technology, Inc. | Cryopreservation of cultured epithelial sheets |
AU663083B2 (en) | 1991-03-26 | 1995-09-28 | State of Oregon acting by and through The State Board of Higher Education on behalf of The Oregon Health Sciences University, The | Product and method for improving keratinocyte adhesion to the dermis |
US5556783A (en) | 1991-03-27 | 1996-09-17 | Trustees Of Univ. Of Penna | Methods of culturing and modulating the growth of hair follicular stem cells |
ES2149779T3 (es) | 1991-11-20 | 2000-11-16 | Innogenetics Nv | Lisados derivados de queratinocitos para utilizacion como substancias cicatrizantes. |
EP0639186B1 (en) | 1992-04-17 | 1999-06-23 | Abbott Laboratories | Taxol derivatives |
US5955343A (en) | 1992-12-28 | 1999-09-21 | Massachusetts Institute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
EP0694142A4 (en) | 1993-05-05 | 1997-10-22 | David F Negrotti | MODULAR EQUIPMENT AND COUPLING SYSTEM FOR LABORATORY PURPOSES |
US5507385A (en) | 1994-08-12 | 1996-04-16 | Rubbermaid Incorporated | Multipurpose storage bin |
US5518612A (en) | 1994-08-30 | 1996-05-21 | Becton, Dickinson And Company | Cell strainer assembly and method of use |
US5650317A (en) | 1994-09-16 | 1997-07-22 | Michigan State University | Human breast epithelial cell type with stem cell and luminal epithelial cell characteristics |
US6238908B1 (en) | 1995-06-07 | 2001-05-29 | Aastrom Biosciences, Inc. | Apparatus and method for maintaining and growth biological cells |
US5851522A (en) | 1995-06-07 | 1998-12-22 | Trustees Of Tufts College | Enhancing keratinocyte migration |
KR100455006B1 (ko) | 1995-12-21 | 2005-01-13 | 소시에떼 데 프로듀이 네슬레 소시에떼아노님 | 향상된불사화사람피부세포계및이의제조에유용한신규한무혈청배지 |
EP1015489B1 (en) | 1996-05-29 | 2006-07-05 | Derek Nigel John Hart | Dendritic cell receptor |
AU3990197A (en) | 1996-10-04 | 1998-04-09 | Metropolitan Health Service Board | Method of engraftment of cultured cells |
IL120909A0 (en) | 1997-05-26 | 1997-09-30 | Lrr & D Ltd | Compositions and means for the treatment of burns and other cutaneous traumas |
US5786207A (en) | 1997-05-28 | 1998-07-28 | University Of Pittsburgh | Tissue dissociating system and method |
IT1293484B1 (it) | 1997-06-11 | 1999-03-01 | Fidia Advanced Biopolymers Srl | Materiale biologico comprendente una efficiente coltura di cellule e una matrice tridimensionale biocompatibile e biodegradabile |
AU740913B2 (en) | 1997-09-11 | 2001-11-15 | Purdue Research Foundation | Galactosidase modified submucosal tissue |
AU1664299A (en) | 1997-10-25 | 1999-05-17 | Roche Diagnostics Gmbh | Autodegradable microcarriers and their use |
WO1999023199A1 (en) * | 1997-10-31 | 1999-05-14 | Baxter International Inc. | Closed system for processing primary tissue |
US20010048917A1 (en) | 1998-03-09 | 2001-12-06 | Warren Hoeffler | Skin equivalent and methods of forming and using same |
US6080581A (en) | 1998-07-02 | 2000-06-27 | Charles Daniel Anderson | Culture vessel for growing or culturing cells, cellular aggregates, tissues and organoids and methods for using same |
US6207451B1 (en) | 1998-09-15 | 2001-03-27 | The Regents Of The University Of Michigan | Mammalian muscle construct and method for producing same |
US6479052B1 (en) | 1998-12-02 | 2002-11-12 | Bristol-Myers Squibb Company | Spray delivery of cells |
JP2002537851A (ja) | 1999-03-09 | 2002-11-12 | アコルディス インダストリアル ファイバース ゲゼルシャフト ミット ベシュレンクテル ハフツング | 作用物質のインビトロテスト法、その装置および使用 |
EP1180135B1 (en) * | 1999-05-28 | 2005-08-17 | Cepheid | Apparatus and method for cell disruption |
US7081240B1 (en) | 2000-06-28 | 2006-07-25 | Zimmer Orthobiologics, Inc. | Protein mixtures for wound healing |
US6673603B2 (en) | 2000-09-01 | 2004-01-06 | Modex Therapeutiques, S.A. | Cell paste comprising keratinocytes and fibroblasts |
US6660853B2 (en) | 2000-12-15 | 2003-12-09 | Al Prescott | Method for purifying high molecular weight hyaluronic acid |
AUPR298901A0 (en) | 2001-02-07 | 2001-03-08 | McComb Foundation, Inc., The | Cell suspension preparation technique and device |
WO2002062358A1 (en) * | 2001-02-07 | 2002-08-15 | Mccomb Foundation Inc. | Cell suspension preparation technique and device |
WO2002066598A1 (de) * | 2001-02-20 | 2002-08-29 | Max-Delbrück-Centrum für Molekulare Medizin | System zur automatischen isolierung von lebenden zellen aus tierischen geweben |
US7585670B2 (en) * | 2001-12-07 | 2009-09-08 | Cytori Therapeutics, Inc. | Automated methods for isolating and using clinically safe adipose derived regenerative cells |
AU2752P (en) | 2002-03-01 | 2005-06-02 | Vletter & Den Haan Beheer B V | WINDSOR Lilium hybrid |
ITPD20020064A1 (it) | 2002-03-12 | 2003-09-12 | Fidia Advanced Biopolymers Srl | Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem |
US9144583B2 (en) | 2002-03-29 | 2015-09-29 | Tissue Genesis, Inc. | Cell separation apparatus and methods of use |
US20050026275A1 (en) * | 2003-06-23 | 2005-02-03 | Andrej Bahoric | Device, system and method for receiving, processing and dispersing cells |
JP2005043617A (ja) * | 2003-07-28 | 2005-02-17 | Konica Minolta Business Technologies Inc | 画像形成装置 |
JP2007530543A (ja) | 2004-03-22 | 2007-11-01 | オシリス セラピューティクス,インコーポレイテッド | 間葉幹細胞及びその使用法 |
US7655465B2 (en) | 2004-06-07 | 2010-02-02 | Massachusetts Institute Of Technology | Methods for ex vivo propagation of somatic hair follicle stem cells |
WO2006014159A2 (en) * | 2004-07-01 | 2006-02-09 | Macropore Biosurgery Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
EP1765980A4 (en) | 2004-07-02 | 2007-12-12 | Cytori Therapeutics Inc | SYSTEMS AND METHOD FOR THE INSULATION AND USE OF CLINICALLY SAFE, FAT-GUN-GENERATING REGENERATIVE CELLS |
US8568761B2 (en) | 2005-07-15 | 2013-10-29 | Cormatrix Cardiovascular, Inc. | Compositions for regenerating defective or absent myocardium |
US8216528B2 (en) * | 2005-09-29 | 2012-07-10 | Sysmex Corporation | Sample preparation kit, sample preparation container, and sample processing device |
GB0520757D0 (en) * | 2005-10-12 | 2005-11-23 | Vuppalapati Gunasekar | Delivery device |
CN102389344B (zh) | 2006-02-07 | 2015-12-16 | 脊柱赛特有限公司 | 采用机械应变使人皮肤成纤维细胞发生软骨形成分化的方法 |
US9259445B2 (en) | 2006-06-07 | 2016-02-16 | Universidad Tecnica Federico Santa Maria | Integrated implant system (IIS) biocompatible, biodegradable and bioactive, comprising a biocompatible sterile porous polymeric matrix and a gel, integrating in situ the tridimensional matrix structure |
US20070286880A1 (en) | 2006-06-08 | 2007-12-13 | Andrey Vasiliev | Inoculated spongiform scaffold for transplantation and tissue regeneration |
US8022037B2 (en) | 2007-01-08 | 2011-09-20 | University Of Southern California | Skin wound healing compositions and methods of use thereof |
WO2009073724A1 (en) * | 2007-12-04 | 2009-06-11 | Ingeneron, Inc. | Apparatus and methods for cell isolation |
CN102089425A (zh) | 2008-05-07 | 2011-06-08 | Ucl商业有限公司 | 仿生细胞支架 |
CN102203580A (zh) * | 2008-09-17 | 2011-09-28 | 高压生物科学公司 | 通过柔和受控压缩转动用于机械分裂的粉碎机 |
CN101423820B (zh) * | 2008-11-28 | 2012-02-01 | 浙江大学 | 基于骨髓间充质干细胞的骨组织分阶段灌流培养方法 |
JP2012513782A (ja) * | 2008-12-24 | 2012-06-21 | バーダー、アウグスティヌス | 個々の移植物としての操作された組織および足場の迅速な調製および使用 |
US9057064B1 (en) * | 2009-02-25 | 2015-06-16 | Ag-Defense Systems, Inc. | Method and apparatus for extracting DNA from a biological sample |
JP5917392B2 (ja) * | 2009-05-01 | 2016-05-11 | ビミニ テクノロジーズ リミテッド ライアビリティ カンパニー | 組織及び細胞富化グラフトを最適化するシステム、方法及び組成物 |
US8207118B2 (en) | 2009-07-17 | 2012-06-26 | University Of Southern California | Skin wound healing compositions and methods of use thereof |
US8921103B2 (en) | 2009-08-28 | 2014-12-30 | Board Of Regents, The University Of Texas System | Laminar construct for tissue-engineered dermal equivalent |
FR2950074B1 (fr) | 2009-09-16 | 2017-10-06 | Oreal | Equivalent de peau in vitro et procede de preparation |
EP2485754A1 (en) | 2009-10-07 | 2012-08-15 | Genogen, Inc. | Methods and compositions for skin regeneration |
CN101914495A (zh) | 2010-07-22 | 2010-12-15 | 吉林大学 | 用于体外大量扩增毛囊干细胞的培养方法 |
US8162247B2 (en) * | 2010-08-17 | 2012-04-24 | Biomedical Polymers, Inc. | Grinding system |
US9150826B2 (en) * | 2011-03-14 | 2015-10-06 | Zymo Research Corporation | Portable sample disruptor apparatus, kits, and methods |
PL3557251T3 (pl) * | 2011-03-22 | 2024-02-05 | Cartiregen B.V. | Układ do przetwarzania komórek chrząstki |
JP2014525260A (ja) * | 2011-08-29 | 2014-09-29 | ステムピューティクス・リサーチ・プライベート・リミテッド | 脂肪組織から間質血管画分(svf)細胞を単離するためのシステムおよびその方法 |
ES2725564T3 (es) * | 2011-11-08 | 2019-09-24 | Auxocell Laboratories Inc | Sistemas y métodos de procesamiento celular |
CA2874091C (en) * | 2012-03-22 | 2023-09-26 | Avita Medical Ltd. | Method for preparing cell suspension comprising undifferentiated/progenitor cells and/or differentiated cells |
FR2991690B1 (fr) | 2012-06-07 | 2020-02-28 | Laboratoires Genevrier | Utilisation d'une chaufferette pour favoriser une reaction biologique |
AU2013205148B2 (en) | 2013-03-14 | 2014-10-30 | AVITA Medical Americas, LLC | Systems and methods for tissue processing and preparation of cell suspension therefrom |
US10436680B2 (en) * | 2013-10-15 | 2019-10-08 | Kianoosh Peyvan | Capture, disruption, and extraction apparatus and method |
-
2013
- 2013-04-13 AU AU2013205148A patent/AU2013205148B2/en active Active
-
2014
- 2014-03-14 JP JP2016502942A patent/JP6479757B2/ja active Active
- 2014-03-14 US US14/776,038 patent/US10626358B2/en active Active
- 2014-03-14 WO PCT/US2014/028944 patent/WO2014153072A1/en active Application Filing
- 2014-03-14 CN CN201480025699.5A patent/CN105189729B/zh active Active
- 2014-03-14 CA CA2906088A patent/CA2906088A1/en active Pending
- 2014-03-14 EP EP19208169.3A patent/EP3674396A1/en active Pending
- 2014-03-14 ES ES14770177T patent/ES2759063T3/es active Active
- 2014-03-14 CN CN201911343417.7A patent/CN111304081A/zh active Pending
- 2014-03-14 EP EP14770177.5A patent/EP2970856B1/en active Active
-
2016
- 2016-06-23 HK HK16107310.0A patent/HK1219291A1/zh unknown
-
2020
- 2020-02-11 US US16/787,882 patent/US11124752B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1625398A (zh) * | 2002-02-01 | 2005-06-08 | 欧里恩公司 | 一种联合治疗急性心肌梗死的方法 |
CN1878470A (zh) * | 2003-09-17 | 2006-12-13 | 马克罗珀尔生物外科公司 | 在周围血管疾病和相关病症的治疗中使用再生细胞的方法 |
WO2013019154A1 (en) * | 2011-07-29 | 2013-02-07 | General Electric Company | Systems, methods and control laws for cell harvesting |
Also Published As
Publication number | Publication date |
---|---|
EP2970856A1 (en) | 2016-01-20 |
EP2970856A4 (en) | 2016-10-26 |
EP2970856B1 (en) | 2019-11-13 |
US20160024450A1 (en) | 2016-01-28 |
EP3674396A1 (en) | 2020-07-01 |
CN105189729A (zh) | 2015-12-23 |
ES2759063T3 (es) | 2020-05-07 |
CA2906088A1 (en) | 2014-09-25 |
AU2013205148B2 (en) | 2014-10-30 |
US10626358B2 (en) | 2020-04-21 |
US11124752B2 (en) | 2021-09-21 |
HK1219291A1 (zh) | 2017-03-31 |
US20200208086A1 (en) | 2020-07-02 |
JP6479757B2 (ja) | 2019-03-06 |
JP2016512689A (ja) | 2016-05-09 |
WO2014153072A1 (en) | 2014-09-25 |
AU2013205148A1 (en) | 2014-10-02 |
CN111304081A (zh) | 2020-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105189729B (zh) | 用于组织处理以及由其制备细胞悬液的系统和方法 | |
US20160361476A1 (en) | System for tissue manipulation | |
US20210121901A1 (en) | Modular device for cell spraying | |
EP2604680A1 (en) | Automatic culture device | |
CN115671393A (zh) | 无创伤地形成的组织组合物、装置、制备方法和治疗方法 | |
JP2020506682A (ja) | 組織凍結保存および回復のためのデバイス | |
US20210123838A1 (en) | Atraumatically formed tissue compositions, devices and methods of preparation and treatment | |
CN108079363A (zh) | 一种用于动物组织脱细胞处理的试剂盒及其应用 | |
CN108030914A (zh) | 一种基底膜胶原材料及其制备方法与应用 | |
CN211066646U (zh) | 一种多功能干细胞组织采集装置 | |
CN211535828U (zh) | 器官支架制备装置 | |
CN112961820A (zh) | 一种皮肤组织采集、提取并制备细胞悬液的方法和装置 | |
CN110553984A (zh) | 一种自动化肝脏检验设备 | |
CN111658827A (zh) | 器官支架制备装置和器官支架制备方法 | |
WO2023209039A2 (en) | Tissue structure isolation using a micro-cutting device and uses of resulting micro-cubes of tissue | |
CN112877180A (zh) | 一种多功能脂肪处理装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1219291 Country of ref document: HK |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: Cambridge County, England Patentee after: Evita Medical Holdings Ltd. Address before: Cambridge County, England Patentee before: AVITA MEDICAL LTD. |
|
CP01 | Change in the name or title of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: California, USA Patentee after: Evita Medical Holdings Ltd. Address before: Cambridge County, England Patentee before: Evita Medical Holdings Ltd. |
|
CP02 | Change in the address of a patent holder | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240401 Address after: California, USA Patentee after: Evita Medical USA LLC Country or region after: U.S.A. Address before: California, USA Patentee before: Evita Medical Holdings Ltd. Country or region before: Australia |